Effects of Shockwave Therapy Versus Radiofrequency
Nøkkelord
Abstrakt
Beskrivelse
With the increasing awareness of the population regarding the high rate of obesity and the number of deaths per year as a result of being overweight, treatments for reducing measures are increasingly sought.
The evidence shows that the accumulation of fat located in the abdominal region is a risk factor for dyslipidemia and arterial hypertension, and a reduction in waist circumference can reduce the potential risk of cardiovascular disease.
In addition to this concern, with the aging of the population and changes in body dimensions due to pregnancy or to a weight loss process, body flaccidity is also a growing cosmetic complaint, and the result is a less firm and pending skin.
Physical exercise is a very important agent for combating excess weight, with special attention to aerobic physical exercise, which is able to decrease body fat tissue and increase the oxidation of fatty acids by 5 to 10 times more than in resting state. The evidence points out that the exercise prescription to decrease fat mass should focus on a high volume of training (30 to 60 minutes) with moderate intensity (40 to 60% of Heart Rate Reserve), performed regularly and mobilizing large muscle groups.
In order to combat abdominal adiposity, as well as the flaccidity of the region, radiofrequency is presented as a possible complementary strategy.
Radiofrequency is an electromagnetic wave that when applied to skin, generates oscillating magnetic fields that move electrically charged particles producing heat in the tissues. The amount of heat produced is dependent on resistance.
Shock wave therapy consists of the application of high energy acoustic waves whose main characteristic is the production of a high pressure pulse induced in a short period of time. This will generate mechanical pressure waves in the tissues, promoting cavitation, with the formation of gas bubbles in the intervening fluids and an increase in local temperature.
The main objective of this study is to compare the effect of 6 sessions of shock wave therapy versus radiofrequency followed by a protocol of moderate aerobic exercise, in the reduction of adiposity and abdominal flaccidity, in females between 18 and 60 years old. As a secondary objective, it is intended to understand the mechanism of fat mobilization by these two therapies.
Datoer
| Sist bekreftet: | 01/31/2020 |
| Først sendt: | 02/17/2020 |
| Anslått påmelding sendt: | 02/19/2020 |
| Først lagt ut: | 02/23/2020 |
| Siste oppdatering sendt: | 02/19/2020 |
| Siste oppdatering lagt ut: | 02/23/2020 |
| Faktisk studiestartdato: | 02/21/2020 |
| Anslått primær ferdigstillelsesdato: | 04/24/2020 |
| Anslått sluttdato for studien: | 06/18/2020 |
Tilstand eller sykdom
Intervensjon / behandling
Device: radiofrequency group
Device: control group
Device: shockwave therapy group
Fase
Armgrupper
| Væpne | Intervensjon / behandling |
|---|---|
| Experimental: shockwave therapy group This group performed aerobic exercise just after shock wave therapy in the abdominal region. | Device: shockwave therapy group The shock wave device corresponds to the BTL-6000 X-Wave TM with a 20mm transmitter multifocal. The parameters used correspond to the pressure set between 2.8 and 3.5 bar, frequency 15 hertz and 3000 pulses per 10x15 cm area. It was used as a means contact gel for ultrasound, reference 033-051. In this procedure the participants found themselves in the supine position, with a pillow under the head and with the bending knees. |
| Experimental: radiofrequency group This group performed aerobic exercise just after radiofrequency in the abdominal region. | Device: radiofrequency group Radiofrequency protocol - The radiofrequency protocol was performed in dorsal decubitus, with the head elevated at 45 degrees. The application was in capacitive mode, with a 7cm electrode, always in movement. The duration of the application was established in 15 minutes, maintaining the local temperature between 40 to 42 celsius degrees at the epidermis. |
| Active Comparator: control group This group only performed aerobic exercise. | Device: control group Aerobic exercise protocol - 40 minutes of aerobic moderate-intensity exercise (45-55% of reserve heart rate) using Karvonen's formula, performed on a cycloergometer. The duration of the exercise was divided into three parts: warm-up (5 minutes); body (30 minutes); and cooling (from 5 to 10 minutes). The entire protocol was monitored through the Polar® brand heart rate monitor and watch. |
Kvalifikasjonskriterier
| Alder Kvalifisert for studier | 18 Years Til 18 Years |
| Kjønn som kan studeres | Female |
| Godtar sunne frivillige | Ja |
| Kriterier | Inclusion Criteria: - Women aged 18 to 60 years Exclusion Criteria: - smoking and drinking habits; - athletes; - people with dietary restrictions; - participants who have had diets to lose weight in the last 3 months or who will start during the study; - pregnant women; - in postpartum less than one year; - breastfeeding; - intending to become pregnant during the study period; - patients with electronic or metallic devices (pacemaker, IUD); - individuals with metabolic (including dyslipidemias); - hematological and renal disorders; - individuals with dermatological changes; - cardiovascular, respiratory, digestive, orthopedic, rheumatological and oncological pathologies; - changes in the immune system or with acute inflammatory processes; - changes in sensitivity or subject to medication (anti-coagulants, corticosteroids up to 6 weeks before, non-steroidal anti-inflammatory drugs, antihistamines, diuretics) |
Utfall
Primære utfallstiltak
1. Cutaneous abdominal tissue thickness [Baseline]
2. Cutaneous abdominal tissue thickness [3 weeks after]
3. Cutaneous abdominal tissue thickness [6 weeks after]
4. Subcutaneous abdominal tissue thickness [Baseline]
5. Subcutaneous abdominal tissue thickness [3 weeks after]
6. Subcutaneous abdominal tissue thickness [6 weeks after]
7. Glycerol concentration [Baseline]
8. Glycerol concentration [3 weeks after]
9. Glycerol concentration [6 weeks after]
10. Lipid profile (LDL, HDL and triglyceride concentrations) [Baseline]
11. Lipid profile (LDL, HDL and triglyceride concentrations) [3 weeks after]
12. Lipid profile (LDL, HDL and triglyceride concentrations) [6 weeks after]
13. Perimetry [Baseline]
14. Perimetry [3 weeks after]
15. Perimetry [6 weeks after]
16. Adipometry [Baseline]
17. Adipometry [3 weeks after]
18. Adipometry [6 weeks after]
19. Inflammatory markers concentration (IL6, CRP, TNF) [Baseline]
20. Inflammatory markers concentration (IL6, CRP, TNF) [3 weeks after]
21. Inflammatory markers concentration (IL6, CRP, TNF) [6 weeks after]
22. Nitrous oxide concentration [Baseline]
23. Nitrous oxide concentration [3 weeks after]
24. Nitrous oxide concentration [6 weeks after]
25. Body composition- body mass [Baseline]
26. Body composition- body mass [3 weeks after]
27. Body composition- body mass [6 weeks after]
28. Body composition- muscle mass [Baseline]
29. Body composition- muscle mass [3 weeks after]
30. Body composition- muscle mass [6 weeks after]
31. Body composition- fat mass [Baseline]
32. Body composition- fat mass [3 weeks after]
33. Body composition- fat mass [6 weeks after]
34. Body composition- visceral fat [Baseline]
35. Body composition- visceral fat [3 weeks after]
36. Body composition- visceral fat [6 weeks after]
37. Body composition- fat body areas [Baseline]
38. Body composition- fat body areas [3 weeks after]
39. Body composition- fat body areas [6 weeks after]
40. Thermography [Baseline]
41. Thermography [3 weeks after]
42. Thermography [6 weeks after]
43. Photography [Baseline]
44. Photography [3 weeks after]
45. Photography [6 weeks after]
Sekundære utfallstiltak
1. skin flaccidity [Baseline]
2. skin flaccidity [3 weeks after]
3. skin flaccidity [6 weeks after]
4. skin flaccidity and localized fat in the abdomen region [Baseline]
5. skin flaccidity and localized fat in the abdomen region [3 weeks after]
6. skin flaccidity and localized fat in the abdomen region [6 weeks after]
